SBI Securities’s Annovis Bio ANVS Stock Holding History

SBI Securities’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2K	Buy	1,572 +25	+2%	+$41	﹤0.01%	2591
2026 Q2	$2.88K	Buy	1,547 +25	+2%	+$49	﹤0.01%	2415
2026 Q1	$3.39K	Sell	1,522 -5	-0.3%	-$14	﹤0.01%	2203
2025 Q4	$5.28K	Buy	1,527 +96	+7%	+$289	﹤0.01%	1993
2025 Q3	$2.96K	Sell	1,431 -32	-2%	-$80	﹤0.01%	2265
2025 Q2	$3.18K	Buy	1,463 +23	+2%	+$45	﹤0.01%	2195
2025 Q1	$2.16K	Buy	1,440 +1,037	+257%	+$3.17K	﹤0.01%	2258
2024 Q4	$2.03K	Buy	+403	New	+$2.92K	﹤0.01%	2316

Other funds holding ANVS

Sherry Group Mountain Home, Arkansas $107M AUM 11.17% 1-Year Est. Return

CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return

Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $606M AUM 21.78% 1-Year Est. Return

Gill Capital Partners Denver, Colorado $366M AUM 12.21% 1-Year Est. Return

Robertson Stephens Wealth Management San Francisco, California $4.14B AUM 13.63% 1-Year Est. Return

RKL Wealth Management Lancaster, Pennsylvania $1.26B AUM 18.95% 1-Year Est. Return

Wilmington Savings Fund Society Wilmington, Delaware $4.39B AUM 17.99% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

DiNuzzo Private Wealth Beaver, Pennsylvania $1.01B AUM 9.69% 1-Year Est. Return

BOK Financial Tulsa, Oklahoma $6.69B AUM 26.84% 1-Year Est. Return

SBI Securities's ANVS Position: Q3 2026 in Review

SBI Securities increased its Annovis Bio (ANVS) stake by 1.6% in Q3 2026, buying an estimated $41 and bringing the position to 1,572 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #2591.

SBI Securities first reported a position in ANVS in Q4 2024 and has held it in 8 quarters since. The position peaked at $5.28K in Q4 2025. 13 funds tracked by Wall St. Rank hold ANVS as of Q3 2026.

SBI Securities held 1,572 shares of Annovis Bio worth $2K as of Q3 2026.
SBI Securities bought 25 Annovis Bio shares in Q3 2026, an estimated $41.
Annovis Bio made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #2591 holding.
SBI Securities first reported a position in Annovis Bio in Q4 2024 and has held it in 8 quarters since.
SBI Securities's Annovis Bio position peaked at $5.28K in Q4 2025.
13 funds tracked by Wall St. Rank held Annovis Bio as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.